Skip to main content

Effect of argon plasma pre-treatment of healing abutments on peri-implant microbiome and soft tissue integration: a proof-of-concept randomized study



Biofilm-free implant surface is ultimate prerequisite for successful soft and bone tissue integration. Objective of the study was to estimate the effects of argon plasma healing abutment pre-treatment (PT) on peri-implant soft-tissue phenotype (PiSP), inflammation, plaque accumulation and the microbiome (PiM) between non-treated (NPT) and treated (PT) abutments following 3-months healing period. The hypothesis was that cell-conductive and antimicrobial properties of PT would yield optimal conditions for soft tissue integration.

Material and Methods

Two months following second-phase surgery, microbiological and clinical parameters were assessed around thirty-six healing abutments with two types of microtopography, smooth surface (MACHINED) and ultrathin threaded microsurface (ROUGH). A two level randomization schema was used to achieve equal distribution and abutments were randomly divided into rough and machined groups, and then divided into PT and NPT groups. PiM was assessed using next-generation DNA sequencing.


PiM bacterial composition was highly diverse already two months post-implantation, consisting of key-stone pathogens, early and late colonizers, while the mycobiome was less diverse. PT was associated with lower plaque accumulation and inflammation without significant impact on PiSP, while in NPT clinical parameters were increased and associated with periopathogens. NPT mostly harbored late colonizers, while PT exerted higher abundance of early colonizers suggesting less advanced plaque formation. Interaction analysis in PT demonstrated S. mitis co-occurrence with pro-healthy Rothia dentocariosa and co-exclusion with Parvimonas micra, Porphyromonas endodontalis and Prevotella oris. PiSP parameters were generally similar between the groups, but significant association between PiM and keratinized mucosa width was observed in both groups, with remarkably more expressed diversity in NPT compared to PT. PT resulted in significantly lower BOP and PI around rough and machined abutments, respectively, without specific effect on PiM and PiSP.


PT contributed to significantly the less advanced biofilm accumulation and inflammation without specific effects on PiSP.

Peer Review reports


Implant therapy is a gold standard treatment for restoration of missing teeth, based on outstanding functional and aesthetic properties it provides to the patient, while preserving adjacent teeth and improving the oral health-related quality of life [1]. However, the constant exposure of dental implants to the abundant oral microflora may affect the quality of the soft and bone tissue integration, while increasing their susceptibility to peri-implant infection. Peri-implantitis is defined as a chronic inflammatory disease of peri-implant tissues, which is induced by multiple etiologic factors, and in particular by dysbiotic bacterial biofilms accumulated on implant surface [2]. This disease is very burdensome for doctors and patients and with tremendous growth of the implant market. Consequentially, peri-implantitis is currently qualified as emerging public health problem due to increasing prevalence (12–45%) and lack of predictive treatment [3, 4]. Therefore, the prevention of peri-implant infection remains the major priority in management of implant patients [5, 6].

Since soft periodontal and peri-implant tissue are the first line defenders against infective threats (60), it is understandable that lack of periodontal ligament comprehensibly represents the Achilles heel of dental implants making them more susceptible to infection and related immunopathologies [8, 9]. The key-elements of the peri-implant soft tissue phenotype (PiSP) responsible for long-term implant success are mucosal thickness (MT), keratinized mucosa width (KMW), and/or supracrestal height (STH) [10]. In context of long-term peri-implant stability, thick tissues and wider KMW better preserve soft and hard peri-implant tissues, by preventing recession, bacterial accumulation and apical penetration, while also stabilizing peri-implant bone remodeling [11,12,13]. However, the PiSP is site-specific and susceptible to changes over the time, as well as environmental factors [10]. In this context, the microbial factors lately receive an increasing attention. Besides its precursor role in future infections, the low-grade inflammation associated with implant surface colonization negatively modulates the healing processes within implant integration affecting its respective solidity and functionality [7, 14]. In brief, the biofilm formation on implant surfaces followed by colonization by pre-existing oral bacterial species occurs within the first minutes of post-implantation. This process is additionally facilitated by implant surface micro and macro topography [15]. The pre-existing species also consist of keystone periopathogens, the inflammophilic bacteria with a prominent immunoevasive capacity, exploiting the immunity for their own growth while shifting the local microbiome into dysbiotic microflora [16, 17]. In context of the healing processes, periopathogens such as Porphyromonas gingivalis and Treponema denticola interfere with macrophage polarization and cause their shifting from M2 pro-healing to M1 pro-inflammatory course with deleterious effects on the quality of soft tissues and bone implant integration [18,19,20]. Regarding soft tissues specifically, bacterial colonization of implant surfaces prevents sealing of epithelial cells and down-regulates fibroblast proliferation [7, 14]. From a functional aspect, the lack of periodontal ligament decreases the overall barrier capacity of soft peri-implant tissues and impairs immunological control over local microflora [21, 22], thus facilitating biofilm accumulation, its apical migration, and conversion into more resistant anaerobic population. Due to these reasons, biofilm-free implant surface is considered a key factor to promote successful implant integration.

Implant healing abutments play a pivotal role in implant integration and shaping of supporting soft and hard tissues [14], thus considerable research has been placed on designing and implementing surface treatments with anti-biofilm properties [21,22,23]. Ghinassi and colleagues noted an improved response of the soft tissues surrounding the laser treated surfaces [24]. Implant surface plasma pre-treatment (PT) is considered promising protocol for dental implants based on their potent anti-biofilm properties, pro-conductive effects on both osteoblasts and fibroblasts and pro-angiogenic effects, collectively providing the optimal conditions for soft and bone integration [23,24,25,26].

Previous studies showed that PT removes surface contaminants from titanium abutments more effectively than other available methods, providing a clean surface suitable for cell adhesion [27]. From the physicochemical aspect, this treatment provides surface activation at the atomic and molecular level, enhancing the wettability, cell adhesion, and concomitant spreading to the dental implant surface [28,29,30]. Moreover, glow discharge PT induces a net-negative charge on the implant surface oxide increasing the functional presentation of the integrin-binding domain, while promoting cell attachment within proportionally accelerated hard and soft tissue integration [31,32,33,34]. In the context of dental implants, the unique advantages of PT are its universal applicability to all types of healing abutments, irrespective of their original physicochemical characteristics, and its wide antimicrobial capacity, even against highly virulent bacteria associated with peri-implantitis [32, 35, 36]. In context of soft tissues, a series of in vitro studies showed the capacity of argon plasma to increase migration, proliferation, and adhesion of human fibroblasts to the implant surface, as well as improving effects on soft tissue integration and angiogenesis [37,38,39]. While an increasing number of in vitro and pre-clinical studies have been published on this treatment, so far very few clinical studies have reported on the outcomes of PT in implantology. Additionally, although the use of high throughput methods is expected to improve the quality of research studies and to accelerate the progress and clinical translation of new biomaterial-based treatments, the use of omics methods is still very rare in periodontology and implantology [40, 41].

Therefore, we hypothesize that pre-treatment of healing abutments by means of argon plasma may positively affect peri-implant microbiome and soft tissue healing processes providing favorable conditions for optimal peri-implant soft tissue integration.

Primary objective of the present study was to estimate the effect of argon plasma pre-treatment (PT) of the healing abutments on peri-implant soft-tissue clinical parameters and microbiome following an initial phase of healing by comparing the clinical and microbiological parameters between treated and non-treated healing abutments after a 3-months healing period. The secondary aim was to investigate the effects of PT of healing abutments with different surface topography (smooth and rough) on soft tissue integration.

Materials and methods

Study design

The present observational study was designed as a proof-of-concept study estimating the effects of argon plasma pre-treatment (PT) of healing abutments on soft tissue integration by comparing the clinical parameters of soft peri-implant tissues and peri-implant microbiome between treated and non-treated implants that were randomly assigned between the groups (Fig. 1). Additionally, to investigate effects of PT on abutments with different surface configuration, the equal number of healing abutments with smooth and rough surface configuration were assigned between the groups according to a second-level randomization schema. The study was conducted in accordance with principles of Helsinki Declaration, experimental protocol was approved by ethics committee (Comitato Etico Lazio 1, Rome, Italy, reference: 813/CE Lazio 1), while patients were informed on study procedures and agreed to participate in the study by signing a written informed consent.

Fig. 1
figure 1

Study design. The study was designed to test hypothesis that argon plasma pre-treatment might provide favorable effects on soft tissue cells and peri-implant microbiome that would contribute to more solid implant soft tissue integration. The standard clinical parameters and peri-implant microbiome were assessed between non-treated and treated healing abutments three months following placement. Additionally, the equal number of abutments with machined and rough surface topography were distributed for each group to secondary assess the effects of experimental treatment of abutments with different surface topography on soft tissue integration within secondary study objective

Study population

The Study population comprised of systemically healthy patients attending the Private clinic in Rome, Italy recruited between January and July 2021. Following periodontal examination, the patients were enrolled in the study if they were systemically healthy and partially edentulous with clear indication for implant placement. Patients were not enrolled in the study if they presented the following exclusion criteria: Implant sites requiring soft or bone tissue grafting; Active periodontal pockets (pocket depth ≥ 4 mm with positive bleeding of probing); Multiple gingival recessions; Intake of antibiotics during follow-up period.

Healing abutments, antimicrobial surface treatment and randomization

Two types of commercial abutments with different microtopography were used in the study including abutments with smooth surface (MACHINED) and rough ultrathin threaded microsurface (ROUGH) (Sweden & Martina, Padua, Italy). Half of the abutments from each group were randomly selected for treatment using argon plasma in a plasma reactor (Diener Electronic GmbH, Jettingen, Germany) to increase the antimicrobial properties of the surface. Treatment conditions included 75 W of power and − 10 MPa of pressure for 12 min performed immediately before abutment connection as previously described [32]

Two-level randomization schema has been computed for 36 abutments to obtain equal distribution of abutments with smooth surface (MACHINED) and Ultrathin Threaded Microsurface (ROUGH) between experimental and control groups as follows:Argon plasma pre-treated abutments (PT) n = 18: MACHINED = 9, ROUGH = 9; Non plasma treated abutments (NPT) n = 18: MACHINED = 9, ROUGH = 9.

Clinical assessment of the soft tissue integration quality

The assessment of soft tissue integration was performed based on standard clinical parameters for soft peri-implant tissues including mucosal thickness (MT), keratinized mucosa width (KMW)m and recession depth couples with standard indicators of biofilm accumulation and reactive inflammation including the plaque index (Pi) and bleeding on probing (BOP). Supracrestal mucosal height (SMH) was the single parameter of peri-implant soft tissue phenotype that was not considered, as it would yield erroneous outcomes in stage of healing abutments.

Peri-implant clinical parameters were recorded using a plastic probe graded in millimeters (Colorevue® Probe Williams, Hu-Friedy, Chicago, IL) at six sites per implant by applying 0.15 N/cm force for each representative implant, while the soft tissue phenotype was estimated for each implant as well. All clinical measurements were performed by one experienced examiner (LC) following calibration (96.8% concordance within ± 1 mm for measurements of PD).

After surgery (Fig. 2), an oral hygiene (OH) home-care regimen was prescribed to the patients following education and patient motivation, which included recommendation for use of adapted interdental hygiene, 7-day use of chlorhexidine (CHX) mouthwash, and usage of an electrical toothbrush.

Fig. 2
figure 2

Clinical image before surgery, after the implant insertion and at the healing time

Collection of microbiological specimens and assessment of bacterial and fungal peri-implant microbiome

Microbiological samples were collected using GUIDOR® Perio-Implant Diagnostic Test (Sunstar Iberia S.L.U, Barcelona,Spain) with sterile paper points and a 2 ml sterile empty Eppendorf tube according to a previously described protocol [42]. The Bacterial and fungal peri-implant microbiome were assessed using Next Generation DNA Sequencing (NGS). In brief, total genomic DNA was isolated (Institut Clinident SAS, Aix en Provence, France) using the QIAcube® HT Plasticware and QIAamp® 96 DNA QIAcube® HT Kit (Qiagen, Hilden, Germany) according to manufacturer’s recommendations. The elution volume was 150 µl, and twenty-five µl of the extracted DNA was transferred for NGS analysis using the PrecisionBIOME® microbial test (Pangea Laboratory, Tustin, CA, USA). PrecisionBIOME® consists of a targeted NGS workflow including library preparation, sequencing of barcoded amplicons, and bioinformatic analysis of microbial sequences to identify and quantify both bacterial and fungal organisms in a clinical specimen at the species level. Positive and negative controls (buffers only) were also included in the NGS-workflow. ZymoBIOMICS Microbial Community Standard (Zymo Research Corporation, Irvine, CA) was used as a positive control to monitor the performance of all steps of the NGS also including the bioinformatic analysis. Bacterial and fungal amplicons were generated following a targeted approach using the 16S rRNA and ITS2 regions, respectively and the Quick-16S™ NGS library prep kit (Zymo Research Corporation, Irvine, CA) according to manufacturer’s instructions. The NGS library was sequenced using the MiSeq sequencing platform (Illumina, San Diego, CA). The sequencing data was analyzed using a proprietary PrecisionBIOME®™ bioinformatics pipeline capable of producing species-level resolution of both bacterial and fungal sequences. Absolute abundance of total bacteria and fungi was determined using the Femto Bacterial and Fungal DNA Quantification kits (Zymo Research Corporation, Irvine, CA) according to manufacturer’s protocols.

Data management

The primary outcome variables were clinical and microbiological parameters between NPT and PT. Secondary outcome variables were intra-group differences in clinical and microbiological parameters between non treated and treated healing abutments with smooth (MACHINED) and rough (ROUGH) surface topography. Sample size calculation was performed for BOP, thus for a power of 80% the estimated sample size was 25 patients.

Clinical parameters were averaged by site and then calculated by patient and by group. Age and gender were compared using Fisher exact test. The inter-group comparison of clinical parameters was performed using Mann–Whitney test irrespective of data distribution given the relatively small sample size, while the correlation of clinical parameters was performed using Spearman’s correlation test. For the purpose of microbiological clustering, PI and BOP were stratified according to number of positive points as: no = 0; low ≤ 2 and high > 2. α- diversity and evenness were calculated using the Shannon index and the number of observed species. Keratinized gingiva width (KGW) was measured in millimeters and stratified in three clusters as follows: KMW1 < 2 mm, KMW2 = 3–4 mm and KMW3 < 4 mm. β-diversity was calculated using the Bray–Curtis distance at the species taxonomic level. Co-occurrence analyses were used to assess microbial interactions with the standard settings of the R packages “stats v3.6.1″ and “co-occur”, respectively. Analyses of variance and false discovery rate control to correct for type I errors were performed using default parameters of the “vegan” package in R with a p-value > 0.05 and the correlation coefficient (r) values of > 0.60 (in absolute values) were considered significant (R version 3.5.2, R Core Team, 2013). Taxonomy heatmaps were generated using a customized Python script to generate hierarchical clustering of samples based on their Bray–Curtis distance. Linear discriminant analysis (LDA) and effect size (LEfSe) were used to identify taxa that were significantly enriched in each group (QIIME version 1.9.1, p value > 0.05 was considered significant). The core microbiome was determined based on taxa present with ≥ 0.1% relative abundance in ≥ 50% of all samples. Species that had a relative abundance of at least 1% in each data set were used in this analysis, and data was visualized using the same software used for statistical analyses (Prism 8.0, GraphPad Software, La Jolla, CA).


The final sample size consisted of 30 periodontally stable patients that completed the study follow-up since four patients (one in each group) had to be excluded because of antibiotic intake during the follow-up period, while two patients (PT-MACHINED) were excluded based on NGS quality control criteria (DNA amplification cycle threshold value greater than negative control > 35). Due to limited sample size, the microbiome analysis is provided only for primary outcome variables, while the microbiome outcomes for the healing abutments with different topographies were not considered for interpretation but they are provided as Additional file 1. Demographic and clinical parameters by groups are shown in Table 1.

Table 1 Clinical parameters between the groups

Clinical parameters between different abutment surfaces

The comparison of clinical parameters between the groups is listed in Table 1. NPT group showed increased BOP (p = 0.036) and PI (p = 0.021) values while the MT and KMW were not affected by the treatment. Regarding the effects of PT on abutments with different configuration, NPT-MACHINED showed higher PI (p = 0.004) and more frequent thick tissues (p = 0.037) compared to PT-MACHINED, while NPT-ROUGH exhibited significantly higher BOP (p < 0.000) when compared to PT-ROUGH. Significant positive correlation was established between BOP and Pi (p = 0.025), while the BOP was negatively correlated with KMW (p = 0.045).

Peri-implant microbiome between NPT and PT healing abutments

The alpha and beta diversities between NPT and PT a were not significantly different between the groups for either bacterial or fungal microbiome (p > 0.05). Peri-implant microbiome analysis showed a diverse bacterial microbiome consisted of 283 different species, and less diverse mycobiome comprising 11 different fungal species (Fig. 3). While bacteria were detected in all samples, fungal species were detected in only 47% of the specimens (14/30). The bacterial (Fig. 3A) and fungal (Fig. 3B) microbiome was characterized by a large degree of inter-sample diversity. Plasma cleaning significantly influenced peri-implant bacterial microbiome at different taxonomic levels (Fig. 4A), while the fungal microbiome remained unaltered and is thus excluded from depiction. At the phylum level, Firmicutes were significantly more abundant in the PT group (p = 0.014), while Actinobacteria were significantly more abundant in the NPT group (p = 0.038). Saccharibacteria were more prevalent in the NPT group, but this difference was not statistically significant. At the species level, the most abundant bacterial species detected in the PT group were Streptococcus mitis/oralis/pneumoniae, Candidatus saccharibacteria sp., and Fusobacterium nucleatum. In the NPT group, the most abundant species were Candidatus saccharibacteria sp., Rothia aeria/dentocariosa, and Janibacter indicus. Four bacterial species were significantly different between the groups including Actinomyces gerencseriae, Streptococcus gordonii, and Streptococcus mitis that were increased in PT, while Neisseria oralis was more abundant in NPT (Fig. 4B; p < 0.05).

Fig. 3
figure 3

Peri-implant microbiome between the groups including bacterial (A) and fungal (B) species abundance with respective taxonomy heatmaps showing the bacterial and fungal diversity at the species level for the four-group comparison following applied sample clustering. A total of 283 different bacterial and 11 fungal species were detected in the datasets

Fig. 4
figure 4

Differences in microbial profiles between PT and NPT groups and core microbiome. A Cladogram generated by LEfSe analysis highlights differences in taxa between argon plasma pre-treated (PT) and non-pre-treated (NPT) healing abutments (p > 0.05). Regions in red indicate taxa that are significantly enriched in the NPT, while regions in green represent taxa enriched in PT. Nods colored in yellow are not significantly different between groups. Each ring represents a taxonomic level, with the phylum level on the inside and the genus level in the outermost ring. B Differences in abundance amongst bacterial species of interest detected in PT versus NPT groups are expressed as bar plots indicating the average relative abundance and standard deviation for each species in the PT (grey) and the NPT group (back). In general, PT increased abundance of Streptococcus gordonii, Streptococcus mitis, and Actinomyces gerencseriae, while NPT healing abutments exhibited increased abundance of Neisseria oralis. The fungal diversity was higher in PT when compared to NPT, but without statistical significance. Marked with an asterisk are the species significantly different between groups (p < 0.05). C Core microbiome analysis panels show the species that are (1) part of a core, shared microbiome between PT and NPT groups (in green), (2) unique for PT group (in blue), and (3) unique for NPT group (in yellow). The core microbiome was calculated as described in the methods section. Briefly, the species had to be present in more than 50% of patients in each group, and at an average abundance of at least 0.1%. Highlighted in a darker shade are those species that were present in at least 2% of relative abundance or higher

Regarding the cluster of periodontal pathogens and commensals, the frequencies and their relative abundances were not significantly different between the groups, but according to LefSe analysis, Granulicatella adiacens, Rothia dentocariosa, and Haemophilus parainfluenzae were more prevalent in the PT group, while Rothia aeria/dentocariosa and Streptococcus mitis/oralis/pneumoniae were more prevalent in the NPT group. The shared core microbiome between the groups have been identified and consisted of Capnocytophaga gingivalis, Fusobacterium nucleatum, Lautropia mirabilis, Prevotella loescheii, and Veillonella dispar (Fig. 4C).

The fungal diversity was higher in PT when compared to NPT, but without statistical significance. The most common fungal species in both groups was Malassezia restricta.

While there were no statistically significant interactions between fungal and bacterial species, significant co-occurrence was observed between bacterial species (Fig. 5). Generally, the most prominent interactions were observed between Streptococcus species suggesting a symbiotic relationship between these species. In the NPT, was observed only positive interactions for Streptococcus mitis/oralis/pneumoniae, Rothia aeria/dentocariosa, Prevotella loescheii, Haemophilus parainfluenzae, Veillonella dispar, Rothia dentocariosa, Fusobacterium nucleatum, Streptococcus mitis and Neisseria oralis. In the PT group, Streptococcus mitis was positively associated with Rothia aeria/dentocariosa and negatively associated with Parvimonas micra, Porphyromonas endodontalis, and Prevotella oris.

Fig. 5
figure 5

Microbial ecology and bacterial co-occurrence. The most expressed interactions were observed between Streptococcus species. In the NPT were observed only positive interactions for Streptococcus mitis/oralis/pneumoniae, Rothia aeria/dentocariosa, Prevotella loescheii, Haemophilus parainfluenzae, Veillonella dispar, Rothia dentocariosa, Fusobacterium nucleatum, Streptococcus mitis and Neisseria oralis. In the PT group, Streptococcus mitis was positively associated with Rothia aeria/dentocariosa and negatively associated with Parvimonas micra, Porphyromonas endodontalis and Prevotella oris. Negative interactions between species are depicted in yellow, positive interactions in blue and insignificant interaction in grey

Association between clinical parameters and peri-implant microbiome

Bacteria identified as discriminants between PT and NPT according to LefSe analysis were correlated with clinical parameters (Fig. 6). In the PT group, Stomatobaculum longum and Staphylococcus epidermidis, were associated with high plaque accumulation (p = 0.027), while the Streptococcus intermedius (p = 0.033) and Actinomyces naeslundii (p = 0.049) were associated with low plaque accumulation. While there was no specific correlation between BOP and microbial signatures, the thin phenotype was positively correlated with S. gordonii in PT (p = 0.030). In the NPT group, lack of plaque was associated with Janibacter indicus and Schaalia sp. (p = 0.023, the high BOP was associated with Treponema denticola (p = 0.035), Tannerella forsythia (p = 0.021) and Prevotella oralis (p = 0.040), while there were no statistically significant associations between microorganisms and phenotypes. The association of microbiome with KMW was assessed only for KMW 2 and KMW 3 since only one patient in NPT and in the PT group exhibited KMW < 2 mm (KMW1). In NPT 22 different genera and 46 different species were significantly more frequent in KMW 3 compared to KMW 2, while 9/46 species were of the genus Streptococcus. In PT the LEfse analysis showed that three species were significantly different between the groups, Neisseria sicca was significantly enriched in KMW 3 (p = 0.011); while Prevotella oris and Fusobacterium nucleatum (p = 0.024 and p = 0.033, respectively), more abundant in KMW 2. No fungal taxa were significantly different between the groups.

Fig. 6
figure 6

LEfSe analysis associating bacterial species with clinical parameters. Cladograms depict taxa that were significantly different between the clinical parameters at different taxonomic levels (p > 0.05). Each ring represents a taxonomic level, with the phylum level on the inside and the genus level in the outermost ring. Nods colored in yellow are not significantly different between groups. In the PT group Stomatobaculum longum and Staphylococcus epidermidis, were associated with high plaque accumulation (p = 0.027), while the Streptococcus intermedius (p = 0.033) and Actinomyces naeslundii (p = 0.049) were associated with low plaque accumulation. Thin phenotype was positively correlated with S. gordonii in PT (p = 0.030). In NPT group lack of plaque was associated with Janibacter indicus and Schaalia sp. (p = 0.0236), the high BOP was associated with Treponema denticola (p = 0.035), Tannerella forsythia (p = 0.021) and Prevotella oralis (p = 0.040), while there were no statistically significant associations between microorganisms and phenotype. As only one patient per group exhibited KMW 1 values the association of microbiome with KMW was assessed only for KMW 2 (3–4 mm) and KMW 3 (> 4 mm). In NPT 22 different genera and 46 different species were significantly more frequent in KMW 3 compared to KMW 2, while 9/46 species were of the genus Streptococcus. In PT three species were significantly different between the two groups, Neisseria sicca was significantly enriched in KMW 3 (p = 0.011); while Prevotella oris (p = 0.024) and Fusobacterium nucleatum (p = 0.033), more abundant in KMW 2. No fungal taxa were significantly different between the groups


Present study demonstrated that argon plasma pre-treatment of healing abutments contributes to the lower soft tissue inflammation and plaque accumulation, Further, it prevents advanced biofilm formation by favorizing predominance of pioneer colonizers over late colonizers that were in turn significantly more abundant around non-treated abutments. PT did not affect soft tissue phenotype at the clinical level, but at the microbiome level was established the association between S. gordonii and thin tissue in PT, and regarding KMW, the abundance of periopathogenic bacteria including Prevotella oris and Fusobacterium nucleatum were observed in patients with narrower KMW in PT.

The advances in biofilm research driven by breakthrough in molecular techniques have changed the face of oral microbiology, revealing far higher diversity of peri-implant microflora with complex interactions and functional behavior in both health and disease [43, 44]. In the context of antimicrobial materials, it is considered that microbiome research may pave the way for optimal anti-infective treatments by unveiling key treatment targets while allowing highly accurate estimation of treatment effectiveness [40, 45]. Finally, it is considered that omics methods are gamechangers in tackling a double-sided complexity of biological systems and material properties, able to provide the highly accurate and sensitive assessment of material-induced biological effects, accelerating its clinical translation for therapeutic use [41, 46]. Hence, the clinical metagenomics becomes indispensable tool for assessment of infective pathologies and their responsiveness on performed treatments in dentistry [47]. The present study has demonstrated a highly diverse microbiome consisting of 283 different bacterial species around healthy implants following a period of initial integration, as previously reported [11, 40, 41]. Within these species, both early and late colonizers, as well as key pathogens were already present two months post-implantation. This finding is in discordance with previous reports that showed presence of key pathogens only six months following implantation [20]. These findings once again confirm the importance of rigorous infection control from the initial healing stage following implant placement [7]. The fungal microbiome is currently in the spotlight of biofilm research related to prominent capacity of fungal species to form polymicrobial biofilms with a diverse spectrum of bacterial species (particularly with streptococcal species) thus contributing to the accumulation and maturation of dysbiotic biofilms [48, 49]. The mycobiome was generally less diverse than bacterial community and Malassezia restricta represented the most prevalent fungi species as previously reported [50, 51], although its exact role in the oral ecosystem is still unknown.

PT improved the clinical parameters of soft tissue inflammation and plaque accumulation, and positively affected peri-implant microbiome, preventing the growth of late colonizers and related biofilm maturation. PT exhibited higher abundance of pioneer or early colonizers such as S. gordonii and S.mitis [46, 47] as well as Actinomyces known to successfully congregate with S. gordonii [52]. In contrast, the NPT group showed a higher abundance of late colonizers like Neisseria oralis [53] suggesting an advanced stage of biofilm formation in NPT. The higher abundance of bacterial species on plasma treated surfaces might be explained by the fact that this treatment increases the surface wettability, which increases cell-attractiveness, even though this treatment was clearly associated with lower plaque accumulation and less inflammation. Future studies are however needed to decipher the specific role of S. gordonii, which is considered a member of the healthy microflora, but also forms synergistic biofilms with Parvimonas micra and Fusobacterium nucleatum, which in turn are associated with peri-implantitis [42, 54]. Given the fact that Fusobacterium nucleatum was also identified as a member of the core microbiome, shows the importance of timely biofilm control. The high-dimensional class comparison using LEfSE method is praised for its capacity to determine the microbiological characteristics/associations relevant for understanding the inter-group differences and the biological relevance/impact on oral health [55]. In this study we found a significant co-occurrence between S.mitis and Rothia dentocariosa and co-exclusion between S.mitis and pathogenic species including P. micra, Porphyromonas endodontalis, and Prevotella oris. This confirms the pattern of peri-implant health associated with Gram-positive cocci and pathological conversion that follows the competitive shift caused by anaerobic species [56, 57]. On the other hand, the NPT group showed a significant increase in plaque accumulation and higher inflammation index values, which were associated with Tanerella forsythia and P. oris comparable to peri-implant mucositis [58, 59]. These results point to the beneficial effects of PT in preventing plaque-induced peri-implant inflammation. However, the more prevalent thin tissue and its established association with abundance of S. gordonii in the PT group requires further investigation.

Although a number of in vitro studies demonstrated the capacity of argon plasma to increase migration, proliferation and adhesion of fibroblasts to the titanium surface [37, 39], the PT did not show specific effect on KGW and MT suggesting rather indirect effect of this pre-treatment in providing favorable conditions for soft-tissue integration than direct pro-conductive effect. However, the variable microbial signatures were associated to different size of KGW. It would be thus worth to disclose possible interfering effects of this periopathogen with soft tissue collagen synthesis since it has been recently suggested that fibroblast plasticity around titanium implants might be altered by the surface characteristics and by the nature of the inflammatory stimuli [60, 61].

Within commitment of the modern health care toward focused cutting-edge therapies for an increased therapeutic index, tackling the complex biologics and its measurement remains the major prerequisite. It is now established that available regenerative procedures in periodontology and implantology provides in average up to 50% of complete success despite autologous origin or high-grade biomimetic concept, mostly due to altered healing processes and the presence of local interfering factors (such as microbial). It is thus proposed that bioactive approaches targeting specific biological factors should favorize healing processes and yield improved treatment outcomes [62, 67]. On the other hand, the rise of precision medicine has been driven by innovations in molecular profiling specifically for biomaterials, as high-throughput methods allowed tackling the complexity of interaction between biomaterials and biologics and allows for a better understanding of correlations between material properties and their effects on complex biological systems. Thus the personalized strategies and use of omics methods from discovery, over development, preclinical evaluation, and implementation of new clinical approaches are holding the promise to overcome erroneous material design and validation methods usually confined to the low-through put approach behind therapies with limited capacity and represents subject of strongest recommendation in medicine and dentistry [68, 69].

Biomaterial-related infections are considered as the most devastating complication of biomaterial use associated with ravaging biological consequences, hence development of anti-infective biomaterials and infection-resistant surfaces is one of the major priorities in biomedical research [70]. The present study has demonstrated that peri-implant microbiome remains highly diverse already during the first month post-implantation in clinically healthy peri-implant tissues, emphasizing the importance of biofilm control from the early stage of implant placement. The anti-infective pre-treatment of healing abutments seems to be a promising approach providing favorable conditions for optimal soft tissue growth and seal able to withstand infective threats. Furthermore, the controversial findings of lower inflammation coupled thin mucosal tissue and high prevalence of Streptococcus gordonii observed in PT confirms the complexity of material-induced biological effects and the critical role of high throughput methods for accurate evaluation of treatment effectiveness and its rapid clinical translation [41, 46]. Thus, the accelerated implementation of comprehensive biological assessment in dental research undoubtfully remains a roadmap toward improved treatment strategies in implantology [44, 47]. Although this study did not primarily aim to assess the effect of PT on abutments with different topography, the findings of decreased BOP in ROUGH + PT compared to ROUGH healing abutments is suggestive that this surface treatment may attenuated reported upregulated inflammatory response, reported for rough surface topography (1). Additionally, the lower Pi was confirmed on MACHINED + PT compared MACHINED, hence considering observed differences between abutments, this proof-of-concept study provides justification for conducting the further research primary oriented toward effects on rough and machined surface abutments in larger sample. Moreover, given the similarity in opportunistic pathobionts identified between peri-implant microbiome and peri-prosthetic infections in orthopedics (such as Staphylococcus aureus) [54, 71], the findings in this study may be transferable toother medical fields, representing another implication for future research.

The present study exhibits some limitations, primary relating to the relatively small sample size and lack assessment of collagen markers that would possibly provide more specific information regarding treatment effects on soft tissue metabolism. Finally, the assessment of biological parameters should represent an integral part of evaluation protocols in pre-clinical and clinical studies assessing soft peri-implant tissues as being able to provide more precise information over the sensitivity of standard clinical parameters.


Within limitations of this study, argon plasma pre-treatment of healing abutments provided positive effects on peri-implant microbiome resulting in decreased biofilm accumulation and lower soft-tissue inflammation, while the qualitative PiSP seems to be unaltered by this protocol.

Availability of data and materials

The raw/processed data required to reproduce these findings cannot be shared at this time as the data also forms part of an ongoing study.


  1. Nickenig HJ, Wichmann M, Andreas SK, Eitner S. Oral health-related quality of life in partially edentulous patients: assessments before and after implant therapy. J Craniomaxillofac Surg. 2008;36(8):477–80.

    Article  Google Scholar 

  2. Berglundh T, Armitage G, Araujo MG, et al. Peri-implant diseases and conditions: consensus report of workgroup 4 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Clin Periodontol. 2018;45(Suppl 20):S286–91.

    Article  Google Scholar 

  3. Derks J, Schaller D, Hakansson J, Wennstrom JL, Tomasi C, Berglundh T. Effectiveness of implant therapy analyzed in a Swedish population: prevalence of peri-implantitis. J Dent Res. 2016;95(1):43–9.

    Article  Google Scholar 

  4. Rakic M, Galindo-Moreno P, Monje A, et al. How frequent does peri-implantitis occur? A systematic review and meta-analysis. Clin Oral Investig. 2018;22(4):1805–16.

    Article  Google Scholar 

  5. Jepsen S, Berglundh T, Genco R, et al. Primary prevention of peri-implantitis: managing peri-implant mucositis. J Clin Periodontol. 2015;42(Suppl 16):S152-157.

    Article  Google Scholar 

  6. Tonetti MS, Chapple ILC, Jepsen S, Sanz M. Primary and secondary prevention of periodontal and peri-implant diseases: introduction to, and objectives of the 11th European workshop on periodontology consensus conference. J Clin Periodontol. 2015;42(Suppl 16):S1-4.

    Article  Google Scholar 

  7. Zhao B, van der Mei HC, Subbiahdoss G, et al. Soft tissue integration versus early biofilm formation on different dental implant materials. Dent Mater. 2014;30(7):716–27.

    Article  Google Scholar 

  8. Belibasakis GN. Microbiological and immuno-pathological aspects of peri-implant diseases. Arch Oral Biol. 2014;59(1):66–72.

    Article  Google Scholar 

  9. Koliaraki V, Prados A, Armaka M, Kollias G. The mesenchymal context in inflammation, immunity and cancer. Nat Immunol. 2020;21(9):974–82.

    Article  Google Scholar 

  10. Avila-Ortiz G, Gonzalez-Martin O, Couso-Queiruga E, Wang HL. The peri-implant phenotype. J Periodontol. 2020;91(3):283–8.

    Article  Google Scholar 

  11. Monje A, Blasi G. Significance of keratinized mucosa/gingiva on peri-implant and adjacent periodontal conditions in erratic maintenance compliers. J Periodontol. 2019;90(5):445–53.

    Article  Google Scholar 

  12. Tavelli L, Barootchi S, Avila-Ortiz G, Urban IA, Giannobile WV, Wang HL. Peri-implant soft tissue phenotype modification and its impact on peri-implant health: a systematic review and network meta-analysis. J Periodontol. 2021;92(1):21–44.

    Article  Google Scholar 

  13. Thoma DS, Naenni N, Figuero E, et al. Effects of soft tissue augmentation procedures on peri-implant health or disease: a systematic review and meta-analysis. Clin Oral Implants Res. 2018;29(Suppl 15):32–49.

    Article  Google Scholar 

  14. Jain SS, Schramm STJ, Siddiqui DA, et al. Effects of multiple implantations of titanium healing abutments: surface characteristics and microbial colonization. Dent Mater. 2020;36(9):e279–91.

    Article  Google Scholar 

  15. Fürst MM, Salvi GE, Lang NP, Persson GR. Bacterial colonization immediately after installation on oral titanium implants. Clin Oral Implant Res. 2007;18(4):501–8.

    Article  Google Scholar 

  16. Hajishengallis G. The inflammophilic character of the periodontitis-associated microbiota. Mol Oral Microbiol. 2014;29(6):248–57.

    Article  Google Scholar 

  17. Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10(10):717–25.

    Article  Google Scholar 

  18. Henderson B, Kaiser F. Bacterial modulators of bone remodeling in the periodontal pocket. Periodontol 2000. 2018;76(1):97–108.

    Article  Google Scholar 

  19. Sela MN, Kohavi D, Krausz E, Steinberg D, Rosen G. Enzymatic degradation of collagen-guided tissue regeneration membranes by periodontal bacteria. Clin Oral Implants Res. 2003;14(3):263–8.

    Article  Google Scholar 

  20. Yu S, Ding L, Liang D, Luo L. Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing α-ketoglutarate production in mice. Mol Oral Microbiol. 2018;33(5):388–95.

    Article  Google Scholar 

  21. Berglundh T, Lindhe J, Jonsson K, Ericsson I. The topography of the vascular systems in the periodontal and peri-implant tissues in the dog. J Clin Periodontol. 1994;21(3):189–93.

    Article  Google Scholar 

  22. Ericsson I, Persson LG, Berglundh T, Marinello CP, Lindhe J, Klinge B. Different types of inflammatory reactions in peri-implant soft tissues. J Clin Periodontol. 1995;22(3):255–61.

    Article  Google Scholar 

  23. Duske K, Jablonowski L, Koban I, et al. Cold atmospheric plasma in combination with mechanical treatment improves osteoblast growth on biofilm covered titanium discs. Biomaterials. 2015;52:327–34.

    Article  Google Scholar 

  24. Ghinassi B, Di Baldassarre A, D’Addazio G, Traini T, Andrisani M, Di Vincenzo G, Gaggi G, Piatelli M, Caputi S, Sinjari B. Gingival response to dental implant: comparison study on the effects of new nanopored laser-treated vs. traditional healing abutments. Int J Mol Sci. 2020;21(17):6056.

    Article  Google Scholar 

  25. Coelho PG, Giro G, Teixeira HS, et al. Argon-based atmospheric pressure plasma enhances early bone response to rough titanium surfaces. J Biomed Mater Res A. 2012;100(7):1901–6.

    Article  Google Scholar 

  26. Fricke K, Koban I, Tresp H, et al. Atmospheric pressure plasma: a high-performance tool for the efficient removal of biofilms. PLoS ONE. 2012;7(8):e42539.

    Article  Google Scholar 

  27. Canullo L, Micarelli C, Lembo-Fazio L, Iannello G, Clementini M. Microscopical and microbiologic characterization of customized titanium abutments after different cleaning procedures. Clin Oral Implants Res. 2014;25(3):328–36.

    Article  Google Scholar 

  28. Pistilli R, Genova T, Canullo L, et al. Effect of bioactivation on traditional surfaces and zirconium nitride: adhesion and proliferation of preosteoblastic cells and bacteria. Int J Oral Maxillofac Implants. 2018;33(6):1247–54.

    Article  Google Scholar 

  29. Duske K, Koban I, Kindel E, et al. Atmospheric plasma enhances wettability and cell spreading on dental implant metals. J Clin Periodontol. 2012;39(4):400–7.

    Article  Google Scholar 

  30. Zhao G, Schwartz Z, Wieland M, et al. High surface energy enhances cell response to titanium substrate microstructure. J Biomed Mater Res A. 2005;74(1):49–58.

    Article  Google Scholar 

  31. Canullo L, Menini M, Santori G, Rakic M, Sculean A, Pesce P. Titanium abutment surface modifications and peri-implant tissue behavior: a systematic review and meta-analysis. Clin Oral Investig. 2020;24(3):1113–24.

    Article  Google Scholar 

  32. Pesce P, Menini M, Santori G, Giovanni ED, Bagnasco F, Canullo L. Photo and plasma activation of dental implant titanium surfaces. A systematic review with meta-analysis of pre-clinical studies. J Clin Med. 2020;9(9):E2817.

    Article  Google Scholar 

  33. Matthes R, Duske K, Kebede TG, et al. Osteoblast growth, after cleaning of biofilm-covered titanium discs with air-polishing and cold plasma. J Clin Periodontol. 2017;44(6):672–80.

    Article  Google Scholar 

  34. Jablonowski L, Fricke K, Matthes R, et al. Removal of naturally grown human biofilm with an atmospheric pressure plasma jet: an in-vitro study. J Biophotonics. 2017;10(5):718–26.

    Article  Google Scholar 

  35. Dunnill C, Patton T, Brennan J, et al. Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process. Int Wound J. 2017;14(1):89–96.

    Article  Google Scholar 

  36. Ulbin-Figlewicz N, Jarmoluk A, Marycz K. Antimicrobial activity of low-pressure plasma treatment against selected foodborne bacteria and meat microbiota. Ann Microbiol. 2015;65(3):1537–46.

    Article  Google Scholar 

  37. Canullo L, Cassinelli C, Götz W, Tarnow D. Plasma of argon accelerates murine fibroblast adhesion in early stages of titanium disk colonization. Int J Oral Maxillofac Implants. 2013;28(4):957–62.

    Article  Google Scholar 

  38. Griffin M, Palgrave R, Baldovino-Medrano VG, Butler PE, Kalaskar DM. Argon plasma improves the tissue integration and angiogenesis of subcutaneous implants by modifying surface chemistry and topography. Int J Nanomed. 2018;13:6123–41.

    Article  Google Scholar 

  39. Zhu X, Chian KS, Chan-Park MBE, Lee ST. Effect of argon-plasma treatment on proliferation of human-skin-derived fibroblast on chitosan membrane in vitro. J Biomed Mater Res A. 2005;73(3):264–74.

    Article  Google Scholar 

  40. Seidlits SK, Kilian KA. Biomaterials for personalized disease models. Acta Biomater. 2021;132:1–3.

    Article  Google Scholar 

  41. Groen N, Guvendiren M, Rabitz H, Welsh WJ, Kohn J, de Boer J. Stepping into the omics era: opportunities and challenges for biomaterials science and engineering. Acta Biomater. 2016;34:133–42.

    Article  Google Scholar 

  42. Canullo L, Radovanović S, Delibasic B, Blaya JA, Penarrocha D, Rakic M. The predictive value of microbiological findings on teeth, internal and external implant portions in clinical decision making. Clin Oral Implants Res. 2017;28(5):512–9.

    Article  Google Scholar 

  43. Daubert DM, Weinstein BF. Biofilm as a risk factor in implant treatment. Periodontol 2000. 2019;81(1):29–40.

    Article  Google Scholar 

  44. Belibasakis GN, Manoil D. Microbial community-driven etiopathogenesis of peri-implantitis. J Dent Res. 2021;100(1):21–8.

    Article  Google Scholar 

  45. Bindas AJ, Kulkarni S, Koppes RA, Koppes AN. Parkinson’s disease and the gut: models of an emerging relationship. Acta Biomater. 2021;132:325–44.

    Article  Google Scholar 

  46. Rasi Ghaemi S, Delalat B, Cetó X, Harding FJ, Tuke J, Voelcker NH. Synergistic influence of collagen I and BMP 2 drives osteogenic differentiation of mesenchymal stem cells: a cell microarray analysis. Acta Biomater. 2016;34:41–52.

    Article  Google Scholar 

  47. Belibasakis GN, Bostanci N, Marsh PD, Zaura E. Applications of the oral microbiome in personalized dentistry. Arch Oral Biol. 2019;104:7–12.

    Article  Google Scholar 

  48. Falsetta ML, Klein MI, Colonne PM, et al. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo. Infect Immun. 2014;82(5):1968–81.

    Article  Google Scholar 

  49. Wan SX, Tian J, Liu Y, Dhall A, Koo H, Hwang G. Cross-kingdom cell-to-cell interactions in cariogenic biofilm initiation. J Dent Res. 2021;100(1):74–81.

    Article  Google Scholar 

  50. Dupuy AK, David MS, Li L, et al. Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal. PLoS ONE. 2014;9(3):e90899.

    Article  Google Scholar 

  51. Peters BA, Wu J, Hayes RB, Ahn J. The oral fungal mycobiome: characteristics and relation to periodontitis in a pilot study. BMC Microbiol. 2017;17(1):157.

    Article  Google Scholar 

  52. Back CR, Douglas SK, Emerson JE, Nobbs AH, Jenkinson HF. Streptococcus gordonii DL1 adhesin SspB V-region mediates coaggregation via receptor polysaccharide of actinomyces oris T14V. Mol Oral Microbiol. 2015;30(5):411–24.

    Article  Google Scholar 

  53. Zaura E, Keijser BJF, Huse SM, Crielaard W. Defining the healthy “core microbiome” of oral microbial communities. BMC Microbiol. 2009;9:259.

    Article  Google Scholar 

  54. Rakic M, Grusovin M, Canullo L. The microbiologic profile associated with peri-implantitis in humans: a systematic review. Int J Oral Maxillofac Implants. 2015.

    Article  Google Scholar 

  55. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.

    Article  Google Scholar 

  56. Charalampakis G, Leonhardt Å, Rabe P, Dahlén G. Clinical and microbiological characteristics of peri-implantitis cases: a retrospective multicentre study. Clin Oral Implants Res. 2012;23(9):1045–54.

    Article  Google Scholar 

  57. Belibasakis GN, Charalampakis G, Bostanci N, Stadlinger B. Peri-implant infections of oral biofilm etiology. Adv Exp Med Biol. 2015;830:69–84.

    Article  Google Scholar 

  58. Gürlek Ö, Gümüş P, Nile CJ, Lappin DF, Buduneli N. Biomarkers and bacteria around implants and natural teeth in the same individuals. J Periodontol. 2017;88(8):752–61.

    Article  Google Scholar 

  59. Zheng H, Xu L, Wang Z, et al. Subgingival microbiome in patients with healthy and ailing dental implants. Sci Rep. 2015;5:10948.

    Article  Google Scholar 

  60. Sanz-Martin I, Doolittle-Hall J, Teles RP, et al. Exploring the microbiome of healthy and diseased peri-implant sites using Illumina sequencing. J Clin Periodontol. 2017;44(12):1274–84.

    Article  Google Scholar 

  61. Andrukhov O, Behm C, Blufstein A, et al. Effect of implant surface material and roughness to the susceptibility of primary gingival fibroblasts to inflammatory stimuli. Dent Mater. 2020;36(6):e194–205.

    Article  Google Scholar 

  62. Hui WL, Ipe D, Perrotti V, et al. Novel technique using cold atmospheric plasma coupled with air-polishing for the treatment of titanium discs grown with biofilm: an in-vitro study. Dent Mater. 2021;37(2):359–69.

    Article  Google Scholar 

  63. Annunziata M, Canullo L, Donnarumma G, Caputo P, Nastri L, Guida L. Bacterial inactivation/sterilization by argon plasma treatment on contaminated titanium implant surfaces: in vitro study. Med Oral Patol Oral Cir Bucal. 2016;21(1):e118-121.

    Article  Google Scholar 

  64. Figuero E, Graziani F, Sanz I, Herrera D, Sanz M. Management of peri-implant mucositis and peri-implantitis. Periodontol 2000. 2014;66(1):255–73.

    Article  Google Scholar 

  65. Hui WL, Perrotti V, Iaculli F, Piattelli A, Quaranta A. The emerging role of cold atmospheric plasma in implantology: a review of the literature. Nanomaterials (Basel). 2020.

    Article  Google Scholar 

  66. Sanz M, Dahlin C, Apatzidou D, et al. Biomaterials and regenerative technologies used in bone regeneration in the craniomaxillofacial region: consensus report of group 2 of the 15th European workshop on periodontology on bone regeneration. J Clin Periodontol. 2019;46(Suppl 21):82–91.

    Article  Google Scholar 

  67. Sculean A, Nikolidakis D, Nikou G, Ivanovic A, Chapple IL, Stavropoulos A. Biomaterials for promoting periodontal regeneration in human intrabony defects: a systematic review. Periodontol 2000. 2015;68(1):182–216.

    Article  Google Scholar 

  68. Giannobile WV, Lang NP, Tonetti MS. Osteology guidelines for oral and maxillofacial regeneration: clinical research. 1st Edition. Quintessence Publishing Co., Ltd, Great Britain; 2014.

  69. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol. 2018;89(Suppl 1):S159–72.

    Article  Google Scholar 

  70. Campoccia D, Montanaro L, Arciola CR. A review of the clinical implications of anti-infective biomaterials and infection-resistant surfaces. Biomaterials. 2013;34(33):8018–29.

    Article  Google Scholar 

  71. Arciola CR, Campoccia D, Montanaro L. Implant infections: adhesion, biofilm formation and immune evasion. Nat Rev Microbiol. 2018;16(7):397–409.

    Article  Google Scholar 

Download references


Not applicable


No funding to declare.

Author information

Authors and Affiliations



LC MR PP: concept/design, acquisition, analysis of data, drafting the paper and final approval. AR AC: concept/design, analysis of data, drafting the paper, and final approval. EC, NI: acquisition, drafting the paper and final approval. MB JK ACP: analysis of data, statistical analysis, drafting the paper, and final approval. All the authors gave a substantial contribution to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND [2] drafting the paper or revising it critically; AND [3] final approval of the version to be published; AND [4] agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any parts of the work are appropriately investigated and resolved. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Paolo Pesce.

Ethics declarations

Ethics approval and consent to participate

Experimental protocol was approved by ethics committee (Comitato Ethico Lazio 1, Rome, Italy, reference: 813/CE Lazio 1), while patients were informed on study procedures and agreed to participate in the study by signing a written informed consent.

Consent for publication

Not applicable.

Competing interests

Paolo Pesce is an editorial board member of BMC Oral Health. All other authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

: (1) Alpha and beta diversities to assess the microbiome composition. (2) Linear discriminant analysis (LDA) effect size (LEfSe) analysis of bacterial composition changes due to treatment of the patient. (3) Heatmaps.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Canullo, L., Rakic, M., Corvino, E. et al. Effect of argon plasma pre-treatment of healing abutments on peri-implant microbiome and soft tissue integration: a proof-of-concept randomized study. BMC Oral Health 23, 27 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: